Patent details

EP2480250 Title: Compositions comprising botulinum toxin A or B for use in the treatment of osteoporosis

Basic Information

Publication number:
EP2480250
PCT Application Number:
PCT/US/2010/049844
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107610933
PCT Publication Number:
WO/2011/038015
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Compositions comprising botulinum toxin A or B for use in the treatment of osteoporosis
French Title of Invention:
Compositions comprenant des toxines botuliques A ou B pour l'utilisation dans la traitement de l'ostéoporose
German Title of Invention:
Zusammensetzungen Botulinumtoxin A oder B enthaltend zur Verwendung bei der Behandlung der Osteoporose
SPC Number:

Dates

Filing date:
22/09/2010
Grant date:
16/04/2014
EP Publication Date:
16/04/2014
PCT Publication Date:
31/03/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/08/2012
EP B1 Publication Date:
16/04/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/09/2014
Expiration date:
22/09/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/09/2010
 
 

Name:
Allergan Inc.
Address:
2525 Dupont Drive, T2-7H, Irvine, CA 92612, United States (US)

Inventor

Name:
RIMANDO Marlon P.
Address:
United States (US)

Priority

Priority Number:
245595 P
Priority Date:
24/09/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages